Skip to main content
. 2015 Nov 9;7(1):798–813. doi: 10.18632/oncotarget.5985

Figure 3. Effects of stromal POSTN expression in predicting postoperative prognoses of CRC patients with or without postoperative chemotherapy in both cohorts.

Figure 3

A. DFS of stage I-II CRC patients without chemotherapy in Shanghai cohort. B. DFS of stage II CRC patients with postoperative chemotherapy in Shanghai cohort. C. DFS of stage III CRC patients with postoperative chemotherapy in Shanghai cohort. D. DSS of stage I-II CRC patients without chemotherapy in Shanghai cohort. E. DSS of stage II CRC patients with postoperative chemotherapy in Shanghai cohort. F. DSS of stage III CRC patients with postoperative chemotherapy in Shanghai cohort. G. DSS of stage I-II CRC patients without chemotherapy in Guangzhou cohort. H. DSS of stage II CRC patients with postoperative chemotherapy in Guangzhou cohort. I. DSS of stage III CRC patients with chemotherapy in Guangzhou cohort. Abbreviations and marks: CRC, colorectal carcinoma; DFS, disease-free survival; DSS, disease-specific survival; •, P > 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001.

HHS Vulnerability Disclosure